Publications

Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas

 Daniel P. Howsmon, Nihat Baysal, Bruce A. Buckingham, Gregory P. Forlenza, Trang T. Ly, David M. Maahs, Tatiana Marcal, Lindsey Towers, Eric Mauritzen, Sunil Deshpande, Lauren M. Huyett, Jordan E. Pinsker, Ravi Gondhalekar, Francis J. Doyle, III, Eyal Dassau, Juergen Hahn,  and B. Wayne Bequette. Journal of Diabetes Science and Technology. 2018.

12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia

Eyal Dassau, Jordan E. Pinsker, Yogish C. Kudva, Sue A. Brown, Ravi Gondhalekar, Chiara Dalla Man, Steve Patek, Michele Schiavon, Vikash Dadlani, Isuru Dasanayake, Mei Mei Church, Rickey E. Carter, Wendy C. Bevier, Lauren M. Huyett, Jonathan Hughes, Stacey Anderson, Dayu Lv, Elaine Schertz, Emma Emory, Shelly K. McCrady-Spitzer, Tyler Jean, Paige K. Bradley, Ling Hinshaw, Alejandro J. Laguna Sanz, Ananda Basu, Boris Kovatchev, Claudio Cobelli and Francis J. Doyle III. “12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.” Diabetes Care (2017): dc171188. doi:10.2337/dc17-1188

Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes.

R. Gondhalekar, E. Dassau, and F.J. Doyle III. “Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes.” Automatica 71: 237-246, 2016. doi:10.1016/j.automatica.2016.04.015